Infographic: Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE).
Naomi WijesinghaSobha SivaprasadPublished in: Eye (London, England) (2023)